Literature DB >> 6184664

Monoclonal antibodies to Leishmania tropica major: specificities and antigen location.

A A de Ibarra, J G Howard, D Snary.   

Abstract

Six murine monoclonal antibodies to Leishmania tropica major have been prepared and the properties of these antibodies studied. Two (WIC 79.3 and 79.7) were L. tropica major species-specific and bound to promastigote cell surfaces, to parasitized macrophages, but not isolated amastigotes. No evidence was found for the production of antibody to the antigenic determinants recognized by WIC 79.3 or 79.7 during L. tropica major infections in mice and hamsters. One antibody (WIC 79.1) bound to sub-cellular organelles of Leishmania species but to a different sub-cellular organelle of Trypanosoma cruzi. Two others bound to the flagellum, one (WIC 79.2) to all Leishmania species, T. cruzi and Trypanosoma brucei, the other (WIC 79.4) only of L. tropica major and L. donovani species. One antibody (WIC 79.5) was directed against an unknown internal antigen found in all Leishmania species and T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184664     DOI: 10.1017/s0031182000056304

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  41 in total

1.  Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major.

Authors:  Anne-Christin Lamerz; Sebastian Damerow; Barbara Kleczka; Martin Wiese; Ger van Zandbergen; Jens Lamerz; Alexander Wenzel; Fong-Fu Hsu; John Turk; Stephen M Beverley; Françoise H Routier
Journal:  Glycobiology       Date:  2010-03-24       Impact factor: 4.313

2.  Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis.

Authors:  M M Rodrigues; M T Xavier; L M Previato; M A Barcinski
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major.

Authors:  Sumit Mukherjee; Wei Xu; Fong-Fu Hsu; Jigesh Patel; Juyang Huang; Kai Zhang
Journal:  Mol Microbiol       Date:  2018-10-21       Impact factor: 3.501

4.  Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

Authors:  G F Späth; L Epstein; B Leader; S M Singer; H A Avila; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.

Authors:  L P Kahl; R Lelchuk; C A Scott; J Beesley
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages.

Authors:  M Kelleher; S F Moody; P Mirabile; A H Osborn; A Bacic; E Handman
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Proteophosphoglycan confers resistance of Leishmania major to midgut digestive enzymes induced by blood feeding in vector sand flies.

Authors:  Nagila Secundino; Nicola Kimblin; Nathan C Peters; Phillip Lawyer; Althea A Capul; Stephen M Beverley; Salvatore J Turco; David Sacks
Journal:  Cell Microbiol       Date:  2010-01-20       Impact factor: 3.715

8.  Inhibition in vivo of both infective Leishmania major and L. mexicana amazonensis mediated by a single monoclonal antibody.

Authors:  M C Debons-Guillemin; I Vouldoukis; A Roseto; C Alfred; C Chopin; I Ploton; L Monjour
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

9.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host.

Authors:  T Aebischer; S F Moody; E Handman
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  The LPG1 gene family of Leishmania major.

Authors:  Kai Zhang; Tamara Barron; Salvatore J Turco; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2004-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.